Research demonstrates better first-year results with combination therapy than with monotherapy in patients with early RA


Initial combination therapy for early rheumatoid arthritis (RA) provides earlier clinical improvement and less progression of joint damage at 2 years compared with initial monotherapy, according to a randomized, controlled trial.

© 2023 MJH Life Sciences

All rights reserved.